Insuficiencia cardiaca avanzada e transplante cardiaco: Envíos recentes
Mostrando ítems 16-20 de 182
-
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial
(Oxford University Press, 2018-04-14)[Abstract] Aims: We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD). Methods and results: ... -
Consenso colombiano de falla cardíaca avanzada: capítulo de Falla Cardíaca, Trasplante Cardíaco e Hipertensión Pulmonar de la Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
(Elsevier, 2019-07-03)[Resumen] La definición más actualizada de falla cardiaca avanzada incluye síntomas refractarios al tratamiento convencional, independiente de la fracción de eyección del ventrículo izquierdo, acompanados ˜ de elevación ... -
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy
(John Wiley & Sons, 2024-03-04)[Abstract] Aims: To evaluate the effect of long-term tafamidis treatment on health-related quality of life (HRQoL) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) enrolled in the Tafamidis in Transthyretin ... -
Sex differences in heart failure with reduced ejection fraction in the GALACTIC-HF trial
(Elsevier on behalf of the American College of Cardiology Foundation, 2023-10-11)[Abstract] Background: Women with heart failure with reduced ejection fraction (HFrEF) receive less guideline-recommended therapy and experience worse quality of life than men. Objectives: The authors sought to assess ... -
Assessing the relationship between molecular rejection and parenchymal injury in heart transplant biopsies
(Wolters Kluwer, 2022-11)[Abstract] Background: The INTERHEART study (ClinicalTrials.gov #NCT02670408) used genome-wide microarrays to detect rejection in endomyocardial biopsies; however, many heart transplants with no rejection have late dysfunction ...